Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 30.59%10.92B | 23.45%8.36B | 20.11%1.98B | 23.78%1.92B | 20.00%6.78B | 1.84B | 20.61%1.74B | 18.79%1.65B | 17.84%1.55B | 16.54%5.65B |
| Cost of revenue | 11.23%1.48B | 21.03%1.33B | 16.20%318.66M | 12.52%306.04M | 25.59%1.1B | 277.44M | 25.59%274.54M | 32.31%274.24M | 30.70%272M | 6.42%874.48M |
| Gross profit | 34.25%9.45B | 23.92%7.04B | 20.89%1.66B | 26.18%1.61B | 18.98%5.68B | 1.56B | 19.72%1.47B | 16.41%1.37B | 15.42%1.28B | 18.61%4.77B |
| Operating expense | 27.09%7.65B | 21.14%6.02B | 16.52%1.4B | 3.63%1.22B | 15.32%4.97B | 1.41B | 7.31%1.18B | 17.03%1.2B | 29.71%1.18B | 18.29%4.31B |
| Operating profit | 76.71%1.79B | 43.41%1.01B | 50.94%263.42M | 309.41%384.97M | 53.08%707.68M | 149.72M | 126.11%289.41M | 12.32%174.52M | -51.58%94.03M | 21.63%462.3M |
| Net non-operating interest income (expenses) | 2,635.73%16M | 580.23%585K | 18.18%13K | 96.88%63K | 82.98%86K | 11K | 32K | 11K | 32K | 27.03%47K |
| Non-operating interest income | 3,133.16%18.91M | 580.23%585K | 18.18%13K | 96.88%63K | 82.98%86K | --11K | --32K | --11K | --32K | 27.03%47K |
| Non-operating interest expense | --2.91M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -138.97%-13.79M | 326.11%35.39M | -105.52%-40K | 247.49%24.45M | -140.25%-15.65M | -270K | 54.75%472K | -47.69%725K | -100.96%-16.58M | -1,217.50%-6.52M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 250.46%59.07M | -234.56%-39.26M | 6.23M | -32.03M | 29.17M | 16.61M | 12.56M | 0 | 0 | 0 |
| Gain(Loss) on derecognition of available-for-sale financial assets | -102.75%-4.67M | 2,312.74%169.92M | -105.93%-7.68M | 0 | 0 | 86.21%-3.73M | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 981.33%3.45M | 49.61%-391K | -1,824.44%-776K | 35K | 187K | -187K | -811K | -98.22%45K | ||
| Income before tax | 56.92%1.85B | 65.70%1.18B | 54.39%258.44M | 392.29%377.45M | 57.65%712.83M | 166.11M | 135.82%302.66M | 9.36%167.39M | -58.77%76.67M | 26.94%452.15M |
| Income tax | 56.05%552.02M | 73.41%353.74M | 54.18%93.41M | 295.52%121.15M | 55.75%204M | 13.07M | 128.13%99.71M | 17.22%60.58M | -48.79%30.63M | -1.05%130.98M |
| Net income | 57.30%1.3B | 62.61%827.41M | 54.51%165.03M | 456.67%256.3M | 58.43%508.83M | 153.04M | 139.78%202.95M | 5.35%106.81M | -63.50%46.04M | 43.48%321.17M |
| Net income continuous operations | 57.30%1.3B | 62.61%827.41M | 54.51%165.03M | 456.66%256.3M | 58.43%508.83M | --153.04M | 139.78%202.95M | 5.35%106.81M | -63.50%46.04M | 43.48%321.17M |
| Noncontrolling interests | -56.93M | 0 | ||||||||
| Net income attributable to the company | 64.18%1.36B | 62.61%827.41M | 54.51%165.03M | 456.67%256.3M | 58.43%508.83M | 153.04M | 139.78%202.95M | 5.35%106.81M | -63.50%46.04M | 43.48%321.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 64.18%1.36B | 62.61%827.41M | 54.51%165.03M | 456.67%256.3M | 58.43%508.83M | 153.04M | 139.78%202.95M | 5.35%106.81M | -63.50%46.04M | 43.48%321.17M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 65.17%42.4 | 62.98%25.67 | 54.38%5.11 | 459.15%7.94 | 59.41%15.75 | 4.74 | 140.61%6.28 | 6.09%3.31 | -63.40%1.42 | 42.57%9.88 |
| Diluted earnings per share | 64.86%42.27 | 62.79%25.64 | 54.08%5.1 | 459.15%7.94 | 59.41%15.75 | 4.74 | 140.61%6.28 | 6.09%3.31 | -63.40%1.42 | 43.40%9.88 |
| Dividend per share | 66.67%5 | 3 | ||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |